Patient-doctor interaction, psychobehavioural characteristics and mental disorders in patients with suspected allergies: Do they predict "medically unexplained symptoms"?

Acta Dermato-Venereologica

Volumn 91, Issue 6, 2011, Pages 666-673

  Hausteiner Wiehle, Constanze ^a   Grosber, Martine ^a   Bubel, Esther ^a   Groben, Sylvie ^a   Bornschein, Susanne ^a   Lahmann, Claas ^a   Eyer, Florian ^a   Eberlein, Bernadette ^a   Rendt, Heidrun Beh ^b   Löwe, Bernd ^c   Henningsen, Peter ^a   Huber, Dorothea ^a,d   Ring, Johannes ^a   Darsow, Ulf ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Klinikum Harlaching   (Germany)

Author keywords

Allergy; Medically unexplained symptoms; Patient doctor interaction; Psychobehavioural characteristics; Somatization

Indexed keywords

HYMENOPTERA VENOM;

ADULT; ALLERGY; ANXIETY DISORDER; ARTICLE; BEHAVIOR; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DOCTOR PATIENT RELATION; EATING DISORDER; FEMALE; HUMAN; IMMUNOTHERAPY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RATING SCALE; SELF EVALUATION; SOMATOFORM DISORDER; SYMPTOM;

ADULT; ANXIETY DISORDERS; COUNTERTRANSFERENCE (PSYCHOLOGY); DEPRESSIVE DISORDER; DIAGNOSTIC SELF EVALUATION; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; SEX FACTORS; SOMATOFORM DISORDERS;

EID: 80054907292     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1147     Document Type: Article

References (43)

1. von Pirquet C. Allergy. [Allergie.] Münch Med Wochenschr 1906; 53: 1457-1458.
2. Shorter E. Multiple chemical sensitivity: pseudodisease in historical perspective. Scand J Work Environ Health 1997; 23: S35-S42.
3. Harth W, Gieler U, Kusnir D, Tausk FA. Clinical management in psychodermatology. Berlin: Springer, 2008.
4. Teufel M, Biedermann T, Rapps N, Hausteiner C, Henningsen P, Enck P, Zipfel S. Psychological burden of food allergy. World J Gastroenterol 2007; 13: 3456-3465.
5. Ring J. Allergy in practice. Berlin: Springer, 2005.
6. Sicherer SH, Leung DY. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2007. J Allergy Clin Immunol 2008; 121: 1351-1358.
7. Fox RA, Sabo BM, Williams TP, Joffres MR. Intradermal testing for food and chemical sensitivities: a double-blind controlled study. J Allergy Clin Immunol 1999; 103: 907-911.
8. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140: 1001-1006.
9. Bornschein S, Hausteiner C, Römmelt H, Nowak D, Förstl H, Zilker T. Double-blind placebo-controlled provocation study in patients with subjective Multiple Chemical Sensitivity (MCS) and matched control subjects. Clin Tox 2008; 46: 443-449.
10. Henningsen P, Fazekas C, Sharpe M. Barriers to improving treatment. In: Creed F, Henningsen P, Fink P, editors. Medically unexplained symptoms, somatisation and bodily distress. Developing better clinical services. Cambridge University Press. Cambridge (in press).
11. Bornschein S, Hausteiner C, Zilker T, Förstl H. Mental and somatic disorders and multiple chemical sensitivity (MCS) in 264 'environmental patients'. Psychol Med 2002; 32: 1387-1394.
12. Papo D, Eberlein-König B, Berresheim HW, Huss-Marp J, Grimm V, Ring J, et al. Chemosensory function and psychological profile in patients with multiple chemical sensitivity: comparison with odor-sensitive and asymptomatic controls. J Psychosom Res 2006; 60: 199-209.
13. Johansson A, Millqvist E, Bende M. Relationship of airway sensory hyperreactivity to asthma and mental morbidity. Ann Allergy Asthma Immunol 2010; 105: 20-23.
14. Bavbek S, Kumbasar H, Tugcu H, Misirligil Z. Psychological status of patients with seasonal and perennial allergic rhinitis. J Investig Allergol Clin Immunol 2002; 12: 204-210.
15. Oude-Elberink JNG, de Monchy JGR, van der Heide S, Guyatt GH, Dubois AEJ. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002; 110: 174-182.
16. Thompson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000; 85: 338-347.
17. Stauder A, Kovacs M. Anxiety symptoms in allergic patients: identification and risk factors. Psychosom Med 2003; 65: 816-823.
18. Chida Y, Hamer M, Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 2008; 70: 102-116.
19. Wright RJ. Stress and atopic disorders. J Allergy Clin Immunol 2005; 116: 1301-1306.
20. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007; 369: 946-955.
21. Hausteiner C, Bornschein S, Bubel E, Groben S, Lahmann C, Grosber M, et al. Psychobehavioural predictors of somatoform disorders in patients with suspected allergies. Psychosom Med 2009; 71: 1004-1011.
22. Brand S, Heller P, Bircher A, Braun-Fahrländer C, Huss A, Niederer M, et al. Interactional behaviour as a marker for screening patients with environment-related complaints. Int J Hyg Environ Health 2007; 210: 79-89.
23. Betan E, Heim AK, Zittel Conklin C, Westen D. Countertransference phenomena and personality pathology in clinical practice: an empirical investigation. Am J Psychiatry 2005; 162: 890-898.
24. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737-1744.
25. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-266.
26. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
27. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097.
28. Moss-Morris R, Weinman J, Petrie K J, Horne R, Cameron LD, Buick D. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002; 17: 1-16.
29. Fink P, Ewald H, Jensen J, Sørensen L, Engberg M, Holm M, Munk-Jørgensen P. Screening for somatisation and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatisation. J Psychosom Res 1999; 46: 261-273.
30. Speckens AEM, Spinhoven P, Van Hemert AM, Bolk JH. The Reassurance Questionnaire (RQ): psychometric properties of a self-report questionnaire to assess reassurability. Psychol Med 2000; 30: 841-847.
31. Noyes R Jr, Langbehn DR, Happel RL, Sieren LR, Muller BA. Health Attitude Survey. A scale for assessing somatizing patients. Psychosomatics 1999; 40: 470-478.
32. Hahn SR. Physical symptoms and physician-experienced difficulty in the physician-patient relationship. Ann Intern Med 2001; 134: 897-904.
33. Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978; 88: 251-258.
34. Parsons T. Definitions of health and illness in the light of American values and social structure. In: Jaco EG, editor. Patients, physicians, and illness: sourcebook in behavioural science and medicine. Glencoe, IL: Free Press, 1958: p. 165-187.
35. Hasler G, Moergeli H, Bachmann R, Lambreva E, Buddeberg C, Schnyder U. Patient satisfaction with outpatient mental treatment: the role of diagnosis, pharmacotherapy, and perceived therapeutic change. Can J Psychiatry 2004; 49: 315-321.
36. Waller E, Scheidt CE. Somatoform disorders as disorders of affect regulation: a development perspective. Int Rev Psychiatry 2006; 18: 13-24.
37. Frostholm L, Fink P, Oernboel E, Christensen KS, Toft T, et al. The uncertain consultation and patient satisfaction: the impact of patients' illness perceptions and a randomized controlled trial on the training of physicians' communication skills, Psychosom Med 2005; 67: 897-905.
38. Frostholm L, Oernboel E, Christensen KS, Toft T, Olesen F, Weinman J, Fink P. Do illness perceptions predict health outcomes in primary care patients? A 2-year follow-up study. J Psychosom Res 2007; 62: 129-138.
39. Saß H, Wittchen HU, Zaudig M. Diagnostisches und Statistisches Manual Psychischer Störungen DSM-IV. Hogrefe, Göttingen 1998, p. 387, p.455, p.500 and pp. 508-528.
40. Fortune G, Barrowclough C, Lobban F. Illness representations in depression. Br J Clin Psychol 2004; 43: 347-364.
41. Quiles Marcos Y, Terol Cantero MC, Romero Escobar C, Pagán Acosta G. Illness perception in eating disorders and psychosocial adaptation. Eur Eat Disord Rev 2007; 15: 373-384.
42. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001; 51: 361-367.
43. K. Patients presenting with somatic complaints: epidemiology, mental comorbidity and management. Int J Methods Psychiatr Res 2003; 12: 34-43. Acta